论文部分内容阅读
目的:评价分析氨溴索注射液辅助治疗支气管肺炎的临床疗效。方法:随机将本社区2011年6月到2014年6月收治的62例患者分为对照组和观察组,临床对对照组患者主要采用常规治疗,对观察组患者在对照组治疗的基础上主要实施氨溴索注射液治疗,并观察两组患者治疗效果。结果:观察组患者的临床总有效率为93.55%明显高于对照组70.97%(P<0.05);观察组不良反应发生率9.68%与对照组6.65%相比无明显差异(P>0.05),同时观察组患者体温恢复时间、啰音消失时间均明显短于对照组患者,其差异具有统计学意义(P<0.05)。结论:氨溴索注射液辅助治疗支气管肺炎的临床效果显著,安全性高,值得推广使用。
Objective: To evaluate the clinical efficacy of ambroxol injection in the treatment of bronchial pneumonia. Methods: Sixty-two patients were randomly divided into control group and observation group from June 2011 to June 2014 in our community. The patients in the control group were treated routinely. The patients in the observation group were mainly treated on the basis of the control group The implementation of ambroxol injection treatment, and observe the treatment effect of two groups of patients. Results: The total clinical effective rate in the observation group was 93.55%, which was significantly higher than that in the control group (70.97%, P <0.05). There was no significant difference between the observation group and the control group (9.68% vs 9.65%, P <0.05) At the same time, the recovery time of body temperature and the disappearance of rales in the observation group were significantly shorter than those in the control group, the difference was statistically significant (P <0.05). Conclusion: Ambroxol injection adjuvant treatment of bronchial pneumonia, the clinical effect of significant, high safety, it is worth promoting the use of.